Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes.
Cayuga Biotech has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Cayuga Biotech's investors include SOSV, IndieBio, NuFund Venture Group, New York Ventures, Gopher Angels.
Cayuga Biotech is headquartered in Bridgewater, United States.
Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes.
Cayuga Biotech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cayuga Biotech — Funding & Investors." VCBacked, December 11, 2025, https://www.vcbacked.co/company/cayuga-biotech. Accessed July 19, 2026.
VCBacked. (2025). Cayuga Biotech — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cayuga-biotech
{{cite web |title=Cayuga Biotech — Funding & Investors |url=https://www.vcbacked.co/company/cayuga-biotech |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated